Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryota Hashimoto

Showing results (291-300 of 467) with videos related to

Pageof 47
Sort By:
Schizophrenia Research|March 2, 2010
Failure to find an association between myosin heavy chain 9, non-muscle (MYH9) and schizophrenia: a three-stage case-control association studyHideki Amagane, Yuichiro Watanabe, Naoshi Kaneko, et al.
Neuropsychopharmacology Reports|April 27, 2019
Efficacy and safety of lithium and lamotrigine for the maintenance treatment of clinically stable patients with bipolar disorder: A systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials with an enrichment designKazuto Oya, Kenji Sakuma, Satoru Esumi, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 14, 2014
Central CRTH2, a second prostaglandin D2 receptor, mediates emotional impairment in the lipopolysaccharide and tumor-induced sickness behavior modelRyota Haba, Norihito Shintani, Yusuke Onaka, et al.
Neuropsychopharmacology Reports|November 7, 2024
The association between benzodiazepine prescriptions and the risk of laxative use in schizophrenia treatmentShinichiro Ochi, Takashi Tsuboi, Naomi Hasegawa, et al.
Journal of Psychiatry & Neuroscience : JPN|February 7, 2018
Decreased serum pyridoxal levels in schizophrenia: meta-analysis and Mendelian randomization analysisYukiko Tomioka, Shusuke Numata, Makoto Kinoshita, et al.
Schizophrenia Research|October 18, 2025
Schizophrenia with hypozincemia: Clinical features and symptom severityKoichi Tabata, Kazuya Toriumi, Kazuhiro Suzuki, et al.
Schizophrenia Research|April 13, 2011
No association between the PCM1 gene and schizophrenia: a multi-center case-control study and a meta-analysisRyota Hashimoto, Kazutaka Ohi, Yuka Yasuda, et al.
Journal of Psychiatry & Neuroscience : JPN|April 25, 2018
Decreased serum pyridoxal levels in schizophrenia: meta-analysis and Mendelian randomization analysisYukiko Tomioka, Shusuke Numata, Makoto Kinoshita, et al.
Schizophrenia Research|September 13, 2013
Replication in a Japanese population that a MIR30E gene variation is associated with schizophreniaYuichiro Watanabe, Yoshimi Iijima, Jun Egawa, et al.
Brain : a Journal of Neurology|December 7, 2005
The association between the Val158Met polymorphism of the catechol-O-methyl transferase gene and morphological abnormalities of the brain in chronic schizophreniaTakashi Ohnishi, Ryota Hashimoto, Takeyuki Mori, et al.
Pageof 47

Showing results (291-300 of 467) with videos related to

Sort By:
Pageof 47
Schizophrenia Research|March 2, 2010
Failure to find an association between myosin heavy chain 9, non-muscle (MYH9) and schizophrenia: a three-stage case-control association studyHideki Amagane, Yuichiro Watanabe, Naoshi Kaneko, et al.
Neuropsychopharmacology Reports|April 27, 2019
Efficacy and safety of lithium and lamotrigine for the maintenance treatment of clinically stable patients with bipolar disorder: A systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials with an enrichment designKazuto Oya, Kenji Sakuma, Satoru Esumi, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 14, 2014
Central CRTH2, a second prostaglandin D2 receptor, mediates emotional impairment in the lipopolysaccharide and tumor-induced sickness behavior modelRyota Haba, Norihito Shintani, Yusuke Onaka, et al.
Neuropsychopharmacology Reports|November 7, 2024
The association between benzodiazepine prescriptions and the risk of laxative use in schizophrenia treatmentShinichiro Ochi, Takashi Tsuboi, Naomi Hasegawa, et al.
Journal of Psychiatry & Neuroscience : JPN|February 7, 2018
Decreased serum pyridoxal levels in schizophrenia: meta-analysis and Mendelian randomization analysisYukiko Tomioka, Shusuke Numata, Makoto Kinoshita, et al.
Schizophrenia Research|October 18, 2025
Schizophrenia with hypozincemia: Clinical features and symptom severityKoichi Tabata, Kazuya Toriumi, Kazuhiro Suzuki, et al.
Schizophrenia Research|April 13, 2011
No association between the PCM1 gene and schizophrenia: a multi-center case-control study and a meta-analysisRyota Hashimoto, Kazutaka Ohi, Yuka Yasuda, et al.
Journal of Psychiatry & Neuroscience : JPN|April 25, 2018
Decreased serum pyridoxal levels in schizophrenia: meta-analysis and Mendelian randomization analysisYukiko Tomioka, Shusuke Numata, Makoto Kinoshita, et al.
Schizophrenia Research|September 13, 2013
Replication in a Japanese population that a MIR30E gene variation is associated with schizophreniaYuichiro Watanabe, Yoshimi Iijima, Jun Egawa, et al.
Brain : a Journal of Neurology|December 7, 2005
The association between the Val158Met polymorphism of the catechol-O-methyl transferase gene and morphological abnormalities of the brain in chronic schizophreniaTakashi Ohnishi, Ryota Hashimoto, Takeyuki Mori, et al.
Pageof 47